Tradestie Institutional Equity Comparison Engine

BHVN vs AGIO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BHVN Overall Edge

BHVN Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biohaven Ltd. (BHVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AGIO counters with relative strength in Valuation. Fundamentally, BHVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AGIO at 2.5x Forward P/E and -297.7% operating margin (+330.0% YoY). In options structure, BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against AGIO sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AGIO
BHVN N/M vs AGIO 2.5x Fwd P/E
Growth & Margin Winner BHVN
Op Margin 0.0% vs -297.7% ยท YoY +0.0% vs +330.0%
Momentum & Technical Winner BHVN
1Y +72.1% vs -28.5% ยท 52W Pos 59% vs 34%
Options & Structure Winner BHVN
CONSOLIDATION (18th %ile IV) vs UNCLASSIFIED (16th %ile IV)
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.90
+0.62% 1D
Market Cap $2.1B
1M Return +28.99%
1Y Return +72.09%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0
AGIO NASDAQ
Agios Pharmaceuticals, Inc.
Pharmaceutical Preparations
$30.42
-3.7% 1D
Market Cap $1.9B
1M Return -2.87%
1Y Return -28.49%
Forward P/E 2.5x
Unified AI Score
55.9 / 100 HOLD
Tech 68.0 Fund 63.0 Flow 50.0 Mom 53.3

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHVN +72.09% AGIO -28.49% Spread: +100.58 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHVN TTM Op. Margin: 0.0% AGIO TTM Op. Margin: -297.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHVN vs AGIO. Trailing 12-month operating profitability (BHVN 0.0% vs AGIO -297.7%) and valuation multiples (BHVN N/M vs AGIO 2.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHVN (4) vs AGIO (6)
Institutional Metric BHVN AGIO Criterion Row Winner
Market Capitalization Scale $2.1B $1.9B Larger Scale BHVN
Trailing P/E Ratio Valuation N/M 2.5x Lower Multiple AGIO
Forward P/E Ratio Valuation N/M 2.5x Lower Multiple AGIO
Revenue Growth (YoY) Growth +0.0% +330.0% Higher Growth AGIO
Operating Margin (TTM) Profitability 0.0% -297.7% Higher Margin BHVN
Net Profit Margin Profitability 0.0% -264.8% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -799.5% -33.0% Higher ROE AGIO
52-Week Range Position Momentum 59% ($8โ€“$18) 34% ($22โ€“$46) Stronger Trend BHVN
Beta / 30D Volatility Risk Regime 1.41ฮฒ ยท 111% Vol 1.12ฮฒ ยท 85% Vol Lower Realized Risk AGIO
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 55.9 / 100 (HOLD) Higher Composite AGIO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHVN vs AGIO Buy Guide
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AGIO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live AGIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHVN nor AGIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.